首頁 › 肌萎縮性側索硬化症 › 麻薩諸塞 › Boston
Boston, MA 的 肌萎縮性側索硬化症 臨床試驗
19 項針對 肌萎縮性側索硬化症 的研究正在 Boston(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
RAPA-501 Therapy for ALS
招募中2/3 期
- Massachusetts General Hospital, Boston
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
招募中3 期
- Sean M. Healey & AMG Center for ALS, Boston
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
招募中2 期
- Dana Farber Cancer Institute, Boston
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
招募中
- Beth Israel Deaconess Medical Center, Boston
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
招募中1/2 期
- Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, Boston
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
招募中2 期
- Zydus US010, Boston
ASSESS ALL ALS Study
招募中觀察性研究歡迎健康志工
- Massachusetts General Brigham, Boston
PREVENT ALL ALS Study
招募中觀察性研究歡迎健康志工
- Massachusetts General Brigham, Boston
Study of COYA 302 for the Treatment of ALS
招募中2/3 期
- Massachusetts General Hospital, Boston
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
招募中觀察性研究歡迎健康志工
- Massachusetts General Hospital, Boston
Tofersen in Non-SOD1 ALS
招募中2 期
- Massachusetts General Hospital, Boston
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
招募中
- Massachusetts General Hospital, Boston
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
招募中
- Massachusetts General Hospital, Boston
EIM Via the Myolex mScan as an ALS Biomarker
招募中觀察性研究
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
招募中
- Massachusetts General Hospital, Boston
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
招募中1 期
- Massachusetts General Hospital, Healey & AMG Center for ALS, Boston
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
招募中觀察性研究
- Mass General Hospital -MGH, Boston
Intermuscular Coherence as a Biomarker for ALS
招募中觀察性研究歡迎健康志工
- Massachusetts General Hospital, Boston
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
招募中觀察性研究歡迎健康志工
- Massachusetts General Hospital, Boston
其他城市的 肌萎縮性側索硬化症 試驗
- Philadelphia, PA14 項研究
- Jacksonville, FL13 項研究
- Baltimore, MD13 項研究
- New York City, NY11 項研究
- San Diego, CA10 項研究
- Chicago, IL10 項研究
- San Francisco, CA10 項研究
- St. Louis, MO9 項研究
- Dallas, TX8 項研究
- Phoenix, AZ8 項研究
- Atlanta, GA8 項研究
- Durham, NC7 項研究
Boston 的其他研究
- 乳癌112 項研究
- 非小細胞肺癌90 項研究
- 癌症(所有類型)85 項研究
- 轉移性癌症63 項研究
- 大腸直腸癌63 項研究
- 肺癌62 項研究
- 卵巢癌61 項研究
- 前列腺癌59 項研究
- 憂鬱症52 項研究
- 子宮內膜癌50 項研究
- 心臟衰竭44 項研究
- 急性髓系白血病44 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。